coronavirus penny stocks to watch march 2020

Coronavirus Penny Stocks To Watch #1: BOQI International Medical Inc.

Finally, BOQI International Medical Inc. (BIMI Stock Report)started to make a move during pre-market trading on Friday. You’ll recall that back in October (the weekend of Oct. 11) was when we first caught wind of this company. At the time BIMI stock was trading around $1.48. Since then we’ve seen shares of the company jump as high as $12, pull-back, jump again, and repeat. But a recent bout of selling pressure took shares back down to lows of $1.85.

Closing out the week, BIMI stock has managed to jump back above $2. The company announced that its subsidiary had entered into a $19 million medical device purchase agreement. The deal is with Shandong Forward Medical Group for numeral medical products. These include isolation gowns, protective coveralls, CT machines, ventilators, radiography systems, and laryngoscopes.

Mr. Tiewei Song, Chief Executive Officer and President of BOQI International Medical Inc. said, “As a health care company, we must do our part to help reduce the secondary risks such as shortage of medical devices. We are committed to working closely with our suppliers and logistics partners to ensure the quality and delivery of our products.”

penny stocks to watch BOQI International Medical (BIMI)

Sign up for our FREE Newsletter and get:

  • The Beginner’s Handbook For Trading Penny Stocks
  • Penny Stock Alerts And Ideas
  • Learn To Trade Penny Stocks
  • Free Access to The Fastest Growing Highest Rated Trading Chatroom
Privacy Policy

Midam Ventures, LLC | (305) 306-3854 | 1501 Venera Ave, Coral Gables, FL 33146 | news@pennystocks.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Do These Penny Stocks Have a Place in Your Portfolio? 5 To Watch

Penny Stocks That’ve Rallied On Recent Milestone News

Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc.

Havn Life to supply psychedelic compounds for clinical trials launched by neuroscience…